Who is sponsoring NCT01556256?

NCT01556256 is sponsored by Children's Oncology Group.

What drugs are being tested in NCT01556256?

Interventions in NCT01556256: Caregiver-Related Intervention or Procedure, Music Therapy, Music Therapy, Quality-of-Life Assessment, Questionnaire Administration.

What condition does NCT01556256 study?

NCT01556256 studies Malignant Neoplasm.

Is NCT01556256 still recruiting?

NCT01556256 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT01556256

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents

Completed NA Last updated 10 October 2023

What this trial tests

NA trial testing Caregiver-Related Intervention or Procedure in Malignant Neoplasm in 124 participants. Completed in 2 October 2023.

Timeline

23 April 2012

Primary endpoint
31 August 2016

2 October 2023

Quick facts

Lead sponsor	Children's Oncology Group
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	124
Start date	23 April 2012
Primary completion	31 August 2016
Estimated completion	2 October 2023
Sites	8 locations across United States

Drugs / interventions tested

Caregiver-Related Intervention or Procedure
Music Therapy
Music Therapy
Quality-of-Life Assessment
Questionnaire Administration

Conditions studied

Malignant Neoplasm — all drugs for Malignant Neoplasm →

Sponsor

Children's Oncology Group — full company profile →

Who can join

Adults 11 to 24, any sex, with Malignant Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized trial studies how well music therapy and parents' education work in improving communication, emotional distress, and recovery in adolescents/young adult patients undergoing treatment for high-risk cancer and their parents. Making a music therapy video may improve communication, emotional distress, and recovery in younger patients undergoing treatment for cancer. It is not yet known whether music therapy and counseling for parents is more effective than information handouts for parents in improving communication and emotional distress in patients undergoing treatment for cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving recruitment and retention of adolescents and young adults with cancer in randomized controlled clinical trials.
Docherty SL, Crane S, Haase JE, Robb SL. · · 2019 · cited 8× · PMID 30973826 · DOI 10.1515/ijamh-2018-0215

Verify or expand the search:

Other trials of Caregiver-Related Intervention or Procedure

Trials testing the same drug.

NCT02345798 — Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregivers · NA · completed

Other recruiting trials for Malignant Neoplasm

Currently open trials in the same condition.

NCT07302347 — A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participan · Phase 1, PHASE2 · recruiting
NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting
NCT07252739 — KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) · Phase 2 · recruiting
NCT07247110 — A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) · Phase 1 · recruiting
NCT07131007 — Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics · recruiting

Other Children's Oncology Group trials

Trials by the same sponsor.

NCT07412002 — Quality of End-of-Life Care for Children With Cancer · not yet recruiting
NCT07498465 — A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant · Phase 1 · withdrawn
NCT07022678 — Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · not yet recruiting
NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
NCT06858501 — Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01556256 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Oncology Group
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01556256.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing